Pigmentation of the skin occurs when the color of the skin gets affected badly.Commonly seen disorders of the skin pigmentation are melisma, vitiligo, albinism, and the skin’ pigment changes due to damage. The treatment of skin pigmentation are UV light therapy, surgery, covering with small patches with long-lasting dyes, corticosteroid creams, light-sensitive medicines, and depigmentation technique which is removal of the remaining pigment from the skin. These are the available treatments done for the pigmentation of the skin. Disorders of pigmentation are at first diagnosed, evaluated and then proper needed treatment is performed in primary care practices.
Request a sample report for a detailed analysis of key players and full segmentation: @ https://www.coherentmarketinsights.com/insight/request-sample/5421
Globally, the market for pigmentation disorder treatment (PDT) is forecasted to report for US$ 6,476.5 million as per value by 2022.
Increase in need for safe and accurate treatment for pigmentation disorder is anticipated to push the market growth of the PDT worldwide in the predicted period. For example, with the rise in incidence of pigmentation disorders, the need for safe and accurate treatment is also rising with an increased pace. Incyte Corporation in July 2022 got approval for Opzelura (ruxolitinib) cream from U.S. Food and Drug Administration (FDA) in treating non-segmental vitiligoin adults and pediatric patients of 12years and more. The maiden FDA approved Opzelura cream for pharmocologic treatment to report on re-pigmentation in patients suffering from vitiligo.
Rise in incidence of pigmentation disorders and the rise in elderly population worldwide is anticipated to provide substantial opportunities of growth for the companies in the market for PDT worldwide. For example, the elderly population is very much susceptible to get the pigmentation disorders, since with age, skin tends to develop more avascular and make the skin pallor marked. As stated by WHO, by the end of 2030, for every 1 in 6 people in the globe will age from 60 years and above and the globe’s people population of 60 years and more will multiply by twice the number i.e., 2.1 Bn by the end of 2050. This is anticipated to boost the growth of the market.
Absence of proper reimbursement policies and the treatment cost’s being quite high is anticipated to hamper the market growth of the disorders of pigmentation treatment worldwide. For example, the cost of the treatment of pigmentation is dependent on the treatment type and the number of sessions needed to rectify the skin. The cost would be rising since a number of sessions will require fir the treatment purpose, thus the procedure cost will be of multiplying nature. Furthermore, in the United States, the Internal Revenue Service Regulations and Rulings lays rules of generic type for the eligible and ineligible items reimbursements.
Global Pigmentation Disorders Treatment Market- Impact of Coronavirus (Covid-19) Pandemic_PR
The COVID-19 pandemic and its outbreak affected the market of the devices of the pigmentation disorder worldwide. Many of the elective surgeries were cancelled across the world at the time of the first wave of the pandemic, since most of the cosmetic processes are categorized as of not much importance. Precisely, the pandemic of COVID-19 had negatively affected the market growth of the devices of the pigmentation treatment.
Globally, the market for PDT worldwide was priced at US$ 6,087.0million in the year 2021 and is predicted to the extent of US$ 9,678.6 million by the year 2028 at a CAGR of 6.9% from 2022 to 2028.
Considering the disorder type, the segment of melisma holds a dominating position in the market for PDT in the year 2021, reporting for 38.1% value of share, raising the consent and the introduction of novel products is anticipated to fuel growth of the segment’s growth in the predicted period.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5421
The main fashion in the market for the devices in the pigmentation disorder is the rising emphasis on the growth of the safe and accurate treatment of the pigmentation disorders. Companies operating in the market are emphasizing on the growth and the introduction of the safe and accurate treatments in the market owing to the rise in incidence of the pigmentation disorders and rise in need for new treatments. This is anticipated to lasts in the predicted period, pushing the growth of the market.
The main companies functioning in the market of the devices of the pigmentation treatment worldwide are Abbvie Inc. (Allergan Inc.), Episciences Inc., L’ORÉAL SA (SkinCeuticals International), and Pfizer Inc.
Incyte Corporation in April 2021 released its two positive analyses of the findings from randomized, dose-ranging, vehicle-controlled Phase 2 study in eavaluation of the ruxolitinib cream, a new non-steroidal, anti-inflammatory, JAK inhibitor therapy for treating adult patients suffering from vitiligo.
Temprian Therapeutics Inc., in November 2019, in-licenced a patent for DNA based drug converting the modified heat shock protein, HSP70i, from the Northwestern University. The patent is the backbone for TT-01 which is a drug under development process by Temprian Therapeutics in treating vitiligo.
Reasons to Purchase This Report
• Current and future of Pigmentation Disorders Treatment Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Direct Purchase This Report with Huge Discount ( Up To 25% Off) @ https://www.coherentmarketinsights.com/insight/buy-now/5421
The Pigmentation Disorders Treatment Market is displayed in 13 Chapters:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities
Chapter 2: Market Competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Pigmentation Disorders Treatment Research Findings and Conclusion, Appendix, methodology and data source
View Press Release: https://www.coherentmarketinsights.com/press-release/pigmentation-disorders-treatment-market-4720
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Phone: U.S.: +1-206-701-6702